The Supreme Court on Tuesday rejected an appeal by Johnson & Johnson to overturn a $2 billion verdict in favor of women who claimed the company’s talc product caused ovarian cancer. The ruling leaves intact a Missouri court decision to award the women the sizeable sum after a jury found that the company’s talc products contain…
Supreme Court Rejects Johnson & Johnson Bid to Toss $2 Billion Talc Verdict
Johnson & Johnson Asks High Court to Void $2 Billion Talc Verdict
WASHINGTON—Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company’s talc products. The case features an array of high-profile attorneys, some in unusual alliances, including former independent counsel Kenneth Starr, who is representing the women who sued…
Johnson & Johnson COVID-19 Vaccine Linked to More Blood Clot Cases: CDC
The U.S. Centers for Disease Control and Prevention (CDC) confirmed more cases of rare blood clots tied to the Johnson & Johnson COVID-19 vaccine, saying that more than two dozen cases have been reported. Dr. Tom Shimabukuro, with the CDC’s vaccine task force, said in an update (pdf) Wednesday that 28 total cases of thrombosis with thrombocytopenia were reported…
Norway Should Exclude J&J, AstraZeneca From Vaccine Scheme: Panel
OSLO—Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson from its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday. However, those who volunteer to take either vaccine should be allowed to do so, it said, stressing the importance of dispelling any vaccine…
Officials Probing Oregon Woman’s Death After Getting Johnson & Johnson Shot
State and federal officials are investigating the death of an Oregon woman who received Johnson & Johnson’s COVID-19 vaccine. The woman has not been identified by name or place or residence and the date of the death has not been disclosed. The Oregon Health Authority said it was notified of the potential adverse event on…
Johnson & Johnson COVID-19 Vaccine Effective, Even Against Variants: Trial
Johnson & Johnson’s COVID-19 vaccine helps protect against moderate to severe illness, newly published clinical trial results show. The jab was 67 percent effective in protecting against moderate to severe COVID-19, the disease caused by the CCP (Chinese Communist Party) virus, at 14 days after vaccination, according to research published in the New England Journal of…
J&J to Cooperate in Study of Rare Blood Clots Linked to CCP Virus Vaccine
Johnson & Johnson has agreed to work with a German scientist studying rare blood clots linked to its vaccine for the CCP virus, which causes the disease COVID-19. Andreas Greinacher, a transfusion medicine expert at Greifswald University, was already studying blood clots in patients who received the AstraZeneca CCP (Chinese Communist Party) virus vaccine. Johnson & Johnson…
J&J Reports $100 Million in Vaccine Sales as Results Top Forecasts
April 20, 2021
admin
AMERICABusinessCCP VirusCompaniesforecastsHealth EducationJohnson JohnsonmillionsalesUSUS NewsVaccineVaccines & SafetyWorld
0 Comment
Johnson & Johnson beat expectations for quarterly earnings and raised its dividend payouts to shareholders on Tuesday, while reporting $100 million in sales of its COVID-19 vaccine, whose use was paused by U.S. regulators last week. The company, which has previously said the vaccine will be available on a not-for-profit basis until the end of…
Possible Link Found Between ‘Unusual Blood Clots’ and J&J Vaccine: EU Agency
European Union’s drug regulator said it has found a possible blood clot link with the Johnson & Johnson vaccine but stressed the benefits of the shot outweigh the risk, coming about a week after U.S. health regulators recommended a pause. The European Medicines Agency (EMA) said its “safety committee concluded that a warning about unusual…
FDA Orders Johnson & Johnson Contractor to Pause Vaccine Production at Plant With Prior Contamination Issue
April 19, 2021
admin
AMERICABusinessCCP VirusCompaniesHealth EducationinspectionJohnson JohnsonUSUS NewsVaccineVaccines & Safety
0 Comment
A contractor that makes ingredients for Johnson & Johnson’s COVID-19 vaccine said in a filing Monday that federal regulators ordered a stoppage to its production of the drug substance for the duration of an inspection at a Maryland facility that was previously plagued with a contamination issue. Emergent BioSolutions, which has a contract to manufacture…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta